NCT05912686View on ClinicalTrials.gov

High-Dose Atorvastatin for Vascular Wall Protection in Thrombectomy Patients

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

162

Participants

Timeline

Start Date

July 1, 2023

Primary Completion Date

December 1, 2025

Study Completion Date

July 31, 2026

Conditions
Mechanical ThrombectomyAcute Ischemic Stroke
Interventions
DRUG

Atorvastatin 80mg

The test group will undergo high-dose atorvastatin treatment (80mg/day) for the first 3 days after the procedure, transitioning to a standard dose (20mg/day) of atorvastatin thereafter.

DRUG

Atorvastatin 20mg

The control group will receive a consistent standard dose (20mg/day) of atorvastatin.

Trial Locations (1)

210009

Zhongda Hospital, Southeast University, Nanjing

All Listed Sponsors
lead

Zhongda Hospital

OTHER